HE 20.8216:106
|
Improving drug abuse treatment |
1 |
HE 20.8216:107
|
Drug abuse prevention intervention research : methodological issues |
1 |
HE 20.8216:108
|
Cardiovascular toxicity of cocaine : underlying mechanisms |
1 |
HE 20.8216:109
|
Longitudinal studies of HIV infection in intravenous drug users : methodological issues in natural history research |
1 |
HE 20.8216:110
|
The Epidemiology of cocaine use and abuse |
1 |
HE 20.8216:111/v.1
|
Molecular approaches to drug abuse research |
1 |
HE 20.8216:112
|
Emerging technologies and new directions in drug abuse research |
1 |
HE 20.8216:113
|
Economic costs, cost-effectiveness, financing, and community-based drug treatment |
1 |
HE 20.8216:114
|
Methodological issues in controlled studies on effects of prenatal exposure to drug abuse |
1 |
HE 20.8216:117
|
Methodological issues in epidemiological, prevention, and treatment research on drug-exposed women and their children |
1 |
HE 20.8216:118
|
Drug abuse treatment in prisons and jails |
1 |
HE 20.8216:120
|
Bioavailability of drugs to the brain and the blood-brain barrier |
1 |
HE 20.8216:121
|
Buprenorphine, an alternative treatment for opioid dependence |
1 |
HE 20.8216:123
|
Acute cocaine intoxication : current methods of treatment |
1 |
HE 20.8216:124
|
Neurobiological approaches to brain-behavior interaction |
1 |
HE 20.8216:125
|
Activation of immediate early genes by drugs of abuse |
1 |
HE 20.8216:127
|
Progress and issues in case management |
1 |
HE 20.8216:128
|
Statistical issues in clinical trials for treatment of opiate dependence |
1 |
HE 20.8216:129
|
Inhalant abuse : a volatile research agenda |
1 |
HE 20.8216:130
|
Drug abuse among minority youth : advances in research and methodology |
1 |